SCHEMBL7869910

SCHEMBL7869910

CCOC(=O)c1[nH]nnc1C(=O)c1ccc(Cl)cc1[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNMA1 Q12791 1/20 0.46
HPGD P15428 4/20 0.44
ALOX15 P16050 1/20 0.42
MAPT P10636 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
LMNA P02545 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NR2F2 P24468 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
POLB P06746 1/20 0.41
ALPL P05186 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7863170 0.92 KCNMA1 (0.46) KCNMA1HPGDALOX15MAPTL3MBTL1
SCHEMBL27371673 0.83 HPGD (0.44) KCNMA1HPGDALDH1A1SMN1; SMN2HTT
SCHEMBL7868379 0.83 ALOX15 (0.50) HPGDALOX15ALDH1A1MEN1KMT2A
SCHEMBL7868349 0.82 MAPT (0.46) KCNMA1HPGDALOX15MAPTL3MBTL1
SCHEMBL7863107 0.81 ALOX15 (0.47) HPGDALOX15ALDH1A1HTTALPL
SCHEMBL7871914 0.79 MAPT (0.40) KCNMA1HPGDMAPTL3MBTL1LMNA
SCHEMBL7874904 0.78 MAPT (0.45) KCNMA1HPGDALOX15MAPTL3MBTL1
SCHEMBL7863171 0.77 HPGD (0.43) KCNMA1HPGDALOX15MAPTL3MBTL1
SCHEMBL7863072 0.77 HPGDS (0.44) KCNMA1HPGDALOX15MAPTL3MBTL1
SCHEMBL27452003 0.74 ALDH1A1 (0.49) KCNMA1MAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313290-B1 Azolobenzazepine derivatives and compositions and method of use thereof ZENECA LIMITED (GB) 2001-11-06 US disclosed
US-6124281-A TREATING STROKES ZENECA LIMITED (GB) 2000-09-26 US disclosed
EP-0888350-A1 AZOLOBENZAZEPINE DERIVATIVES AS NEUROLOGICALLY ACTIVE AGENTS ZENECA LIMITED (GB) 1999-01-07 EP disclosed
WO-1997032883-A1 AZOLOBENZAZEPINE DERIVATIVES AS NEUROLOGICALLY ACTIVE AGENTS ZENECA LIMITED (GB) 1997-09-12 WO disclosed